| Followers | 144 |
| Posts | 28022 |
| Boards Moderated | 4 |
| Alias Born | 02/07/2004 |
Friday, January 15, 2021 8:14:52 AM
EVGN trades in TASE (Tel-Aviv Stock Exchange)
Sunday thru Thursday inclu.
Fri & Sat TASE closed.
Your quote is end trade Thursday in TASE.
The market leader is in the Naz due to the
average larger volume in any single day.
Sunday thru Thursday inclu.
Fri & Sat TASE closed.
Your quote is end trade Thursday in TASE.
The market leader is in the Naz due to the
average larger volume in any single day.
Recent EVGN News
- Evogene Shares Decline After Revenue Miss Despite Stronger-Than-Expected Earnings (EVGN) • IH Market News • 05/20/2026 01:59:09 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 12:45:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/20/2026 11:00:14 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/18/2026 08:01:21 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 03:17:06 PM
- Evogene to Present at the 24th Schrödinger European User Group Meeting • PR Newswire (US) • 05/12/2026 12:00:00 PM
- Evogene Schedules First Quarter 2026 Financial Results Release • PR Newswire (US) • 05/07/2026 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 08:01:08 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/02/2026 08:03:36 PM
- Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification • PR Newswire (US) • 04/02/2026 08:01:00 PM
- Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock • PR Newswire (US) • 03/31/2026 12:00:00 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 03/26/2026 08:30:22 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/26/2026 08:28:33 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/26/2026 08:26:46 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/26/2026 08:00:39 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:27:44 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:06:13 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:03:42 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2026 12:00:07 PM
- Evogene Reports Fourth Quarter and Full Year 2025 Financial Results • PR Newswire (US) • 03/05/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/25/2026 01:00:32 PM
- Evogene Releases CEO Letter to Shareholders • PR Newswire (US) • 02/25/2026 01:00:00 PM
